1.
|
BTK blocks the inhibitory effects of MDM2 on p53 activity: M. Rada, et al.; Oncotarget 8, 106639 (2017), Abstract; Full Text
|
2.
|
Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signalling: P.X. Wang, et al.; Nat. Commun. 7, 10592 (2016), Application(s): In vitro ubiquitination assays, Abstract; Full Text
|
3.
|
Host cell-catalyzed S-palmitoylation mediates Golgi targeting of the Legionella ubiquitin ligase GobX: Y.H. Lin, et al.; J. Biol. Chem. 290, 25766 (2015), Application(s): Western Blot, Abstract; Full Text
|
4.
|
TRIM30α Is a Negative-Feedback Regulator of the Intracellular DNA and DNA Virus-Triggered Response by Targeting STING: Y. Wang, et al.; PLoS Pathog. 11, e1005012 (2015),Application(s): In vitro ubiquitination assay, Abstract; Full Text
|
5.
|
TRIM35 negatively regulates TLR7- and TLR9-mediated type I interferon production by targeting IRF7: Y. Wang, et al.;FEBS Lett. 589, 1322 (2015), Application(s): In vitro ubiquitination assay, Abstract;
|
6.
|
Parkin loss of function contributes to RTP801 elevation and neurodegeneration in Parkinson's disease: J. Romaní-Aumedes, et al.; Cell Death Dis. 5, e1364 (2014), Abstract;
|
7.
|
Rlim, an E3 ubiquitin ligase, influences the stability of Stathmin protein in human osteosarcoma cells: X. Chen, et al.; Cell Signal. 26, 1532 (2014), Abstract;
|
8.
|
Stability of the human pregnane X receptor is regulated by E3 ligase UBR5 and serine/threonine kinase DYRK2: S.S. Ong, et al.; Biochem. J. 459, 193 (2014), Abstract;
|
9.
|
Ubiquitin-proteasome-mediated degradation of S-RNase in a solanaceous cross-compatibility reaction: T. Entani, et al.; Plant J. 78, 1014 (2014), Abstract;
|
10.
|
E3 ubiquitin ligase RNF126 promotes cancer cell proliferation by targeting the tumor suppressor p21 for ubiquitin-mediated degradation: X. Zhi, et al.; Cancer Res. 73, 385 (2013), Abstract;
|
11.
|
The E3 ubiquitin ligase MARCH8 negatively regulates IL-1β-induced NF-κB activation by targeting the IL1RAP coreceptor for ubiquitination and degradation: R. Chen, et al.; Proc. Natl. Acad. Sci. U.S.A. 109, 14128 (2012), Abstract; Full Text
|
12.
|
TRIM32 protein modulates type I interferon induction and cellular antiviral response by targeting MITA/STING protein for K63-linked ubiquitination: J. Zhang, et al.; J. Biol. Chem. 287, 28646 (2012), Abstract;
|
13.
|
Cullin 4B protein ubiquitin ligase targets peroxiredoxin III for degradation: X. Li, et al.; J. Biol. Chem. 286, 32344 (2011), Abstract; Full Text
|
14.
|
Tripartite motif 8 (TRIM8) modulates TNFα- and IL-1β-triggered NF-κB activation by targeting TAK1 for K63-linked polyubiquitination: Q. Li, et al.; Proc. Natl. Acad. Sci. U.S.A. 108, 19341 (2011), Abstract; Full Text
|
15.
|
1-Benzyl-1,2,3,4-tetrahydroisoquinoline binds with tubulin beta, a substrate of parkin, and reduces its polyubiquitination: R. Kohta, et al.; J. Neurochem. 114, 1291 (2010), Abstract;
|
16.
|
Pasteurella multocida Toxin-induced Pim-1 expression disrupts suppressor of cytokine signalling (SOCS)-1 activity: D. Hildebrand, et al.; Cell. Microbiol. 12, 1732 (2010), Abstract;
|
17.
|
The E3 ubiquitin ligase RNF5 targets virus-induced signaling adaptor for ubiquitination and degradation: B. Zhong, et al.; J. Immunol. 184, 6249 (2010), Abstract; Full Text
|
18.
|
The Fbw7 tumor suppressor targets KLF5 for ubiquitin-mediated degradation and suppresses breast cell proliferation: D. Zhao, et al.; Cancer Res. 70, 4728 (2010), Abstract; Full Text
|
19.
|
REUL is a novel E3 ubiquitin ligase and stimulator of retinoic-acid-inducible gene-I: D. Gao, et al.; PLoS One 4, e5760(2009), Abstract; Full Text
|